Reply to the letter to the editor 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance' by Funck-Brentano et al.

E Funck-Brentano J C Alvarez C Longvert E Abe A Beauchet P Saiag C Funck-Brentano

Ann Oncol

Department of Pharmacology and CIC-1421, AP-HP, Pitié-Salpêtrière Hospital, Paris INSERM, CIC-1421 and UMR ICAN 1166, Paris Faculty of Medicine, Sorbonne Universités, UPMC Univ Paris 06, Paris, France

Published: February 2016

Download full-text PDF	Source
http://dx.doi.org/10.1093/annonc/mdv549	DOI Listing

Publication Analysis

Top Keywords

reply letter

letter editor

editor 'plasma

'plasma vemurafenib

vemurafenib concentrations

concentrations advanced

advanced brafv600mut

brafv600mut melanoma

melanoma patients

patients impact

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!